Your browser is no longer supported. Please, upgrade your browser.
We’ve redesigned our maps and bubbles! Read more about the new features here. ×
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 1 #1
TickerAZN [NYSE]
CompanyAstraZeneca PLC
CountryUnited Kingdom
IndustryDrug Manufacturers - Major
Market Cap87.02BEPS (ttm)0.98
P/E70.31EPS this Y-52.00%
Forward P/E17.12EPS next Y-4.69%
PEG87.88EPS past 5Y-28.40%
P/S3.33EPS next 5Y0.80%
P/B4.43EPS Q/Q40.50%
Dividend5.52%Sales Q/Q-2.40%
Insider Own-Inst Own7.70%
Insider Trans-Inst Trans15.57%
Short Float0.10%Earnings-
Analyst Recom2.50Target Price77.73
Avg Volume1.84M52W Range59.33 - 79.38
Feb-27-15 11:48AMHorizon Pharma Soars On Q4 Beat, Guidance Raise at Investor's Business Daily
Feb-26-15 10:26AM(OFFICIAL)-UPDATE 1-Actavis' superbug antibiotic gets U.S. approval (Feb. 25) Reuters
Feb-26-15 09:45AMRigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers at American City Business Journals
Feb-25-15 10:30AMCan Isis Pharmaceuticals (ISIS) Beat Earnings this Season? - Analyst Blog Zacks
Feb-25-15 10:06AMNektar Therapeutics Incurs Narrower-than-Expected Q4 Loss - Analyst Blog Zacks
Feb-25-15 09:32AMAlkermes Falls on Pipeline News; Q4 Earnings Plunge Y/Y - Analyst Blog Zacks
Feb-23-15 06:26PMAgilent-ONO Companion Diagnostics Aim - Analyst Blog Zacks
Feb-23-15 03:05PMPatents mean big business to big pharma Market Realist
Feb-23-15 11:28AMSalix Pharmaceuticals: Will Another Buyer Push Valeant's Bid Higher? at Barrons.com
Feb-20-15 01:40PMMedImmune, NIST announce five-year partnership for biological drug research at American City Business Journals
1